BACKGROUND: Glutathione has a wide range of functions; it is an endogenous anti-oxidant and plays a key role in the maintenance of intracellular redox balance and detoxification of xenobiotics. Several studies have indicated that children with autism spectrum disorders may have altered glutathione metabolism which could play a key role in the condition. METHODS: A systematic literature review and meta-analysis was conducted of studies examining metabolites, interventions and/or genes of the glutathione metabolism pathways i.e. the γ-glutamyl cycle and trans-sulphuration pathway in autism spectrum disorders. RESULTS: Thirty nine studies were included in the review comprising an in vitro study, thirty two metabolite and/or co-factor studies, six intervention studies and six studies with genetic data as well as eight studies examining enzyme activity. CONCLUSIONS: The review found evidence for the involvement of the γ-glutamyl cycle and trans-sulphuration pathway in autistic disorder is sufficiently consistent, particularly with respect to the glutathione redox ratio, to warrant further investigation to determine the significance in relation to clinical outcomes. Large, well designed intervention studies that link metabolites, cofactors and genes of the γ-glutamyl cycle and trans-sulphuration pathway with objective behavioural outcomes in children with autism spectrum disorders are required. Future risk factor analysis should include consideration of multiple nutritional status and metabolite biomarkers of pathways linked with the γ-glutamyl cycle and the interaction of genotype in relation to these factors.
BACKGROUND:Glutathione has a wide range of functions; it is an endogenous anti-oxidant and plays a key role in the maintenance of intracellular redox balance and detoxification of xenobiotics. Several studies have indicated that children with autism spectrum disorders may have altered glutathione metabolism which could play a key role in the condition. METHODS: A systematic literature review and meta-analysis was conducted of studies examining metabolites, interventions and/or genes of the glutathione metabolism pathways i.e. the γ-glutamyl cycle and trans-sulphuration pathway in autism spectrum disorders. RESULTS: Thirty nine studies were included in the review comprising an in vitro study, thirty two metabolite and/or co-factor studies, six intervention studies and six studies with genetic data as well as eight studies examining enzyme activity. CONCLUSIONS: The review found evidence for the involvement of the γ-glutamyl cycle and trans-sulphuration pathway in autistic disorder is sufficiently consistent, particularly with respect to the glutathione redox ratio, to warrant further investigation to determine the significance in relation to clinical outcomes. Large, well designed intervention studies that link metabolites, cofactors and genes of the γ-glutamyl cycle and trans-sulphuration pathway with objective behavioural outcomes in children with autism spectrum disorders are required. Future risk factor analysis should include consideration of multiple nutritional status and metabolite biomarkers of pathways linked with the γ-glutamyl cycle and the interaction of genotype in relation to these factors.
Authors: Steven Buyske; Tanishia A Williams; Audrey E Mars; Edward S Stenroos; Sue X Ming; Rong Wang; Madhura Sreenath; Marivic F Factura; Chitra Reddy; George H Lambert; William G Johnson Journal: BMC Genet Date: 2006-02-10 Impact factor: 2.797
Authors: Anna E Esparham; Teri Smith; John M Belmont; Michael Haden; Leigh E Wagner; Randall G Evans; Jeanne A Drisko Journal: Integr Med (Encinitas) Date: 2015-04
Authors: Jacob A S Vorstman; Jeremy R Parr; Daniel Moreno-De-Luca; Richard J L Anney; John I Nurnberger; Joachim F Hallmayer Journal: Nat Rev Genet Date: 2017-03-06 Impact factor: 53.242
Authors: Mohammad H Rahbar; Maureen Samms-Vaughan; Jianzhong Ma; Jan Bressler; Katherine A Loveland; Manouchehr Hessabi; Aisha S Dickerson; Megan L Grove; Sydonnie Shakespeare-Pellington; Compton Beecher; Wayne McLaughlin; Eric Boerwinkle Journal: Res Autism Spectr Disord Date: 2015-04-01
Authors: Svitlana Shpyleva; Samuil Ivanovsky; Aline de Conti; Stepan Melnyk; Volodymyr Tryndyak; Frederick A Beland; S Jill James; Igor P Pogribny Journal: PLoS One Date: 2014-11-25 Impact factor: 3.240
Authors: Alice M S Durieux; Jamie Horder; M Andreina Mendez; Alice Egerton; Steven C R Williams; C Ellie Wilson; Debbie Spain; Clodagh Murphy; Dene Robertson; Gareth J Barker; Declan G Murphy; Grainne M McAlonan Journal: Autism Res Date: 2015-08-20 Impact factor: 5.216
Authors: Janet K Kern; Boyd E Haley; David A Geier; Lisa K Sykes; Paul G King; Mark R Geier Journal: Int J Environ Res Public Health Date: 2013-08-20 Impact factor: 3.390